Iceland no longer approving variations to EU's centralised procedure drugs
This article was originally published in SRA
Executive Summary
The Icelandic Medicines Agency has dispensed with its practice of formally approving variations to medicinal products that have been evaluated through the European Union's centralised procedure1.